You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Caffeine, Cognition, and Socioeconomic Status

Issue title: Therapeutic Opportunities for Caffeine in Alzheimer's Disease and Other Neurodegenerative Disorders

Guest editors: Rodrigo A. Cunhax and Alexandre de Mendonçay

Article type: Research Article

Authors: Kyle, Janet | Fox, Helen C. | Whalley, Lawrence J.; *

Affiliations: School of Medicine & Dentistry, Division of Applied Health Sciences, Foresterhill, University of Aberdeen, Aberdeen, UK | [x] Center for Neuroscience and Cell Biology of Coimbra and Faculty of Medicine, University of Coimbra, Portugal | [y] Institute of Molecular Medicine and Faculty of Medicine, University of Lisbon, Portugal

Correspondence: [*] Correspondence to: Lawrence J. Whalley MD, School of Medicine & Dentistry, Division of Applied Health Sciences, Foresterhill, University of Aberdeen, Aberdeen, AB25 2ZH, UK. Tel.: +44 1224 557950; E-mail: [email protected].

Keywords: Alcohol, anxiety, attention, caffeine, childhood intelligence, neuroticism, non-verbal reasoning, processing speed, smoking, socioeconomic status, spatial ability, verbal memory

DOI: 10.3233/JAD-2010-1409

Journal: Journal of Alzheimer's Disease, vol. 20, no. s1, pp. S151-S159, 2010

Published: 14 April 2010
Get PDF open access

Abstract

There is interest in age-related cognitive decline and environmental risk factors for Alzheimer's disease (AD). This interest is focused on individual differences in exposure to agents that may harm or protect cognitive function. Caffeine is used as a short acting mental stimulant and may possess longer-term properties that protect against age-related decline and, possibly, AD. The current study aimed to: 1) examine current cognitive function in a narrow age range sample (n=351) without dementia (MMSE>25) who are, by reason of age, entering the period of increased risk of AD; and 2) link cognitive function to self-reported intake of caffeine and socioeconomic status (SES). Possible confounding by gender, childhood intelligence, education, and symptoms of anxiety and depression was introduced into the statistical model. There were significant differences between SES groups in caffeine intake (p< 0.05) and cognitive performance (p< 0.001). Higher quartiles of caffeine intake were associated with slower digit symbol speed (F =3.38, p< 0.02) but this finding was removed after allowing for SES. The results are discussed in terms of the withdrawal effects of caffeine during cognitive testing and strong links between SES and cognitive performance. No evidence in support of cognitive enhancing effects of caffeine was found.

Show more